Novartis AG ADR (NVS) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $140.57 (-0.25%), Market cap $285.28B, P/E ratio 21.45, 52-week low–high $110.71 ~ $168.62.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with
Financial statements, price targets, institutional (13F) holdings and related news for Novartis AG ADR are updated in real time on BlackAll Trade.
7 recent posts · 6 bullish · 0 bearish · 1 neutral.
Novartis AG ADR trades at $140.57 (-0.25%). Real-time quotes and charts are available on BlackAll Trade.
Novartis AG ADR has a market cap of about $285.28B. Its P/E ratio is 21.45.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprily